Role of SF Gene Cluster in Autoimmunity
Role of SF Gene Cluster in Autoimmunity
批准号:
6835659
负责人:
Edward K. Wakeland
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-15 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. The Slel congenic interval contains a cluster of genes that initiate the autoimmune cascade leading to fatal lupus in the NZM2410 mouse. Positional cloning analysis has identified a seven gene cluster on mouse chromosome 1 containing the CD150 family of genes (CD48, Lyl08, Csl, CD84, CD244, CD150, CD229) as causative for a breach in tolerance to nuclear antigens. These genes modulate activation thresholds and effector function in many lymphocyte lineages. Our comparison of B6 and B6.Slelb revealed the existence of several structural and regulatory polymorphisms in this gene family. We propose to characterize the impact of these polymorphisms on immune function as follows: 1) To assess the expression of the CD150/CD2 family of genes in vivo. Expression profiles of this gene cluster will be determined in various lymphoctye populations isolated from B6 and B6.Slelb mice prior to and following disease onset. This will be accomplished by a combination of flow cytometry, RT-PCR analysis and the generation of transgenic mice with reporter constructs under the control of regulatory elements of individual CD150 member genes. 2) To characterize the impact of CD150 family gene polymorphisms on lymphocyte function. Functional studies will be performed on B and T cells isolated from B6 and B6.Slelb mice. This will allow us to determine the impact of polymorphisms at the CD150 gene cluster on lymphocyte function in an otherwise genetically identical background. 3) To create an animal model to assess CD150 family member function. The goal of this aim is to generate a mouse strain in which the entire CD150 gene cluster has been deleted using Cre recombinase and flanking LoxP sites. These mice will be essential to study the role of this gene family in lymphocyte function in vivo. In addition, these mice will be used to reconstitute CD150 family member expression by BAC transgenic rescue to assess the role of individual or combinations of CD150 family members in immune function. 4) To assess the impact of the CD150 cluster polymorphisms on autoimmunity. We have developed B6-derived (autoimmune resistant) and 129Sv-derived (autoimmune prone) BAC contigs spanning the CD150 gene cluster for the generation of BAC transgenic mice. These will be used in combination with the CD150 cluster deletion mouse strain to definitively characterize the autoimmune potential of these genes singly or in combination. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:8274819
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2011
-
负责人:Edward K. Wakeland
-
依托单位:
Genetic Mechanisms to Suppress Autoimmunity
-
批准号:8274813
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2011
-
负责人:Edward K. Wakeland
-
依托单位:
Mouse Core
-
批准号:8274816
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2011
-
负责人:Edward K. Wakeland
-
依托单位:
Administrative Core
-
批准号:7694132
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2008
-
负责人:Edward K. Wakeland
-
依托单位:
Genetic Mechanisms to Suppress Autoimmunity
-
批准号:7628043
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2008
-
负责人:Edward K. Wakeland
-
依托单位:
Mouse Core
-
批准号:7628046
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2008
-
负责人:Edward K. Wakeland
-
依托单位:
Genetic Mechanisms to Suppress Autoimmunity
-
批准号:7336587
-
项目类别:
-
资助金额:$25.31万
-
财政年份:2007
-
负责人:Edward K. Wakeland
-
依托单位:
Mouse Core
-
批准号:7336594
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2007
-
负责人:Edward K. Wakeland
-
依托单位:
Administrative Core
-
批准号:7336593
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2007
-
负责人:Edward K. Wakeland
-
依托单位:
Defining genetic pathways to severe systemic autoimmunity
-
批准号:7088247
-
项目类别:
-
资助金额:$57.54万
-
财政年份:2006
-
负责人:Edward K. Wakeland
-
依托单位:
Defining genetic pathways to severe systemic autoimmunity
-
批准号:7193418
-
项目类别:
-
资助金额:$57.39万
-
财政年份:2006
-
负责人:Edward K. Wakeland
-
依托单位:
Defining genetic pathways to severe systemic autoimmunity
-
批准号:7385152
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2006
-
负责人:Edward K. Wakeland
-
依托单位:
Defining genetic pathways to severe systemic autoimmunity
-
批准号:7588029
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2006
-
负责人:Edward K. Wakeland
-
依托单位:
Defining genetic pathways to severe systemic autoimmunity
-
批准号:7799194
-
项目类别:
-
资助金额:$60.45万
-
财政年份:2006
-
负责人:Edward K. Wakeland
-
依托单位:
Role of SF Gene Cluster in Autoimmunity
-
批准号:6597244
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2003
-
负责人:Edward K. Wakeland
-
依托单位:
Role of SF Gene Cluster in Autoimmunity
-
批准号:7001224
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2003
-
负责人:Edward K. Wakeland
-
依托单位:
Role of SF Gene Cluster in Autoimmunity
-
批准号:7159393
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2003
-
负责人:Edward K. Wakeland
-
依托单位:
Role of SF Gene Cluster in Autoimmunity
-
批准号:6800752
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2003
-
负责人:Edward K. Wakeland
-
依托单位:
GENETIC DISSECTION OF LUPUS SUSCEPTIBILITY USING CONGENIC MOUSE STRAINS
-
批准号:6201318
-
项目类别:
-
资助金额:$15.69万
-
财政年份:1999
-
负责人:Edward K. Wakeland
-
依托单位:
CORE--BIOLOGY FACILITY
-
批准号:6201322
-
项目类别:
-
资助金额:$15.69万
-
财政年份:1999
-
负责人:Edward K. Wakeland
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人参皂苷Rb2抑制p300介导的赖氨酸 10 位点 SF3A2 乙酰化,调控Fscn1减轻肾脏缺血/再灌注损伤
-
批准号:2026JJ82134
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张影莉
-
依托单位:
SF6气体氛围下多组分低浓度分解气体在微纳米受限空间的运移机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡敏
-
依托单位:
超声响应SF/TE-BaTiO3压电凝胶调控BMSCs纤维软骨细胞分化促半月板修复作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:傅德杰
-
依托单位:
靶向TM4SF1促进肝细胞癌衰老并增敏免疫治疗的机制研究
-
批准号:JCZRYB202500422
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
负载人牙周膜干细胞外泌体的湿组织高粘附性SF/HA/TA水凝胶体系在骨再生中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张文涛
-
依托单位:
基于微波等离子体技术的SF6废气无害化高效处理体系的构建与工程应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
TM6SF2 E167K、PNPLA3 I148M基因多态性与非酒精性脂肪肝病的关联分析
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:于丽侠
-
依托单位:
剪接因子 SF3B1 R625 位突变通过高强度异常剪接 NF1/RASA1/RASA2 偏好性
驱动黑色素瘤发生的机制
-
批准号:24ZR1442800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:姜芮昕
-
依托单位:
剪接体蛋白SF3B1调控水稻热胁迫响应的机理及应用探究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:凌宇
-
依托单位:
剪接因子SF3B4调控线粒体定位促进肺腺癌转移和顺铂耐药的研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:蔡莉
-
依托单位: